POSTER: AML-751 Clinical Efficacy and Safety of Enasidenib in Newly Diagnosed IDH2-Mutated Acute Myeloid Leukemia (AML): A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Department
Internal Medicine
Document Type
Poster
Publication Title
Clinical Lymphoma Myeloma and Leukemia
Conference Name
Society of Hematologic Oncology (SOHO) Annual Meeting
Conference Date
2025-09-03 - 2025-09-06
First Page
S194
DOI
10.1016/S2152-2650(25)00569-5
Volume
25
Issue
Supplement 1
Publication Date
9-1-2025
Recommended Citation
Mylavarapu, M., Kodali, L. S., Ganatra, N., Medarametla, R., Pasnoor, D. S., Sanjeevi, A., & Jain, P. (2025). POSTER: AML-751 Clinical Efficacy and Safety of Enasidenib in Newly Diagnosed IDH2-Mutated Acute Myeloid Leukemia (AML): A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Clinical Lymphoma Myeloma and Leukemia, 25 (Supplement 1), S194. https://doi.org/10.1016/S2152-2650(25)00569-5
COinS